The Center for Innovative NeuroTech Advancement (CINTA) & NeuroTech Harbor (NTH) announce the Cycle 4 Award Competition supported by the NIH Blueprint MedTech Program. This program is seeking collaborative projects aimed at developing emerging technologies into commercially viable, clinically focused solutions for disorders of the nervous system.
CINTA and NTH are calling for proposals leading to commercialization of groundbreaking preventative, therapeutic, and/or diagnostic medical devices. At a minimum, projects should have already clearly demonstrated proof-of-concept. The technologies proposed must have a pathway to a prototype ready for first-in-human testing within 4 years and have a viable pathway to commercial development.
Applications must focus on an intended use involving the nervous system or addressing consequences of such a disease or injury in an area of interest of the Participating Institutes/Centers.
Two kinds of awards may be issued for applications submitted to this solicitation:
- Optimizer awards will rarely exceed $500,000 in direct costs per year for a period of up to 4 years. In addition to monetary support, awardees will receive mentoring and resources and support services necessary for translation will be available.
- Seedling awards provide support for six months, a $25,000 stipend, and $25,000 to hire subject matter experts. Mentors will work with awardees throughout the project to help resolve specifically identified gap on the path to commercialization.
Applicants must submit pre-proposals through the Blueprint MedTech: Incubator Hubs Program online application system no later than 11:59 pm ET on February 29, 2024. Pre-proposals are submitted through a simple online application form equivalent to approximately three pages.
Eligible applicants will be invited to submit full proposals through the same online application system. The full proposal form is equivalent to approximately ten pages and will undergo review by CINTA and NTH.
To learn more about the award and apply, visit their website here. Weekly informational webinars and office hours by appointment are available in February 2024.